Sikkema, Lisa http://orcid.org/0000-0001-9686-6295
Ramírez-Suástegui, Ciro
Strobl, Daniel C.
Gillett, Tessa E. http://orcid.org/0000-0002-5447-1727
Zappia, Luke http://orcid.org/0000-0001-7744-8565
Madissoon, Elo
Markov, Nikolay S. http://orcid.org/0000-0002-3659-4387
Zaragosi, Laure-Emmanuelle http://orcid.org/0000-0001-6747-7928
Ji, Yuge
Ansari, Meshal
Arguel, Marie-Jeanne http://orcid.org/0000-0002-8725-2555
Apperloo, Leonie
Banchero, Martin
Bécavin, Christophe http://orcid.org/0000-0003-1555-3153
Berg, Marijn
Chichelnitskiy, Evgeny
Chung, Mei-i
Collin, Antoine
Gay, Aurore C. A. http://orcid.org/0000-0002-1593-2674
Gote-Schniering, Janine
Hooshiar Kashani, Baharak
Inecik, Kemal http://orcid.org/0000-0001-7379-9093
Jain, Manu
Kapellos, Theodore S.
Kole, Tessa M.
Leroy, Sylvie
Mayr, Christoph H.
Oliver, Amanda J. http://orcid.org/0000-0003-1690-9027
von Papen, Michael http://orcid.org/0000-0001-5030-1643
Peter, Lance
Taylor, Chase J.
Walzthoeni, Thomas
Xu, Chuan
Bui, Linh T. http://orcid.org/0000-0003-3152-8978
De Donno, Carlo
Dony, Leander http://orcid.org/0000-0001-5697-6991
Faiz, Alen
Guo, Minzhe http://orcid.org/0000-0002-5502-9172
Gutierrez, Austin J. http://orcid.org/0000-0003-2977-2189
Heumos, Lukas
Huang, Ni
Ibarra, Ignacio L. http://orcid.org/0000-0002-0582-002X
Jackson, Nathan D.
Kadur Lakshminarasimha Murthy, Preetish
Lotfollahi, Mohammad http://orcid.org/0000-0001-6858-7985
Tabib, Tracy
Talavera-López, Carlos
Travaglini, Kyle J. http://orcid.org/0000-0003-3164-6448
Wilbrey-Clark, Anna
Worlock, Kaylee B. http://orcid.org/0000-0002-5656-7634
Yoshida, Masahiro http://orcid.org/0000-0002-3521-5322
Chen, Yuexin
Hagood, James S.
Agami, Ahmed
Horvath, Peter
Lundeberg, Joakim
Marquette, Charles-Hugo
Pryhuber, Gloria
Samakovlis, Chistos
Sun, Xin
Ware, Lorraine B.
Zhang, Kun
van den Berge, Maarten
Bossé, Yohan http://orcid.org/0000-0002-3067-3711
Desai, Tushar J. http://orcid.org/0000-0002-8794-5319
Eickelberg, Oliver
Kaminski, Naftali http://orcid.org/0000-0001-5917-4601
Krasnow, Mark A. http://orcid.org/0000-0002-1976-5471
Lafyatis, Robert http://orcid.org/0000-0002-9398-5034
Nikolic, Marko Z. http://orcid.org/0000-0001-6304-6848
Powell, Joseph E.
Rajagopal, Jayaraj
Rojas, Mauricio
Rozenblatt-Rosen, Orit http://orcid.org/0000-0001-6313-3570
Seibold, Max A. http://orcid.org/0000-0002-8685-4263
Sheppard, Dean http://orcid.org/0000-0002-6277-2036
Shepherd, Douglas P.
Sin, Don D. http://orcid.org/0000-0002-0756-6643
Timens, Wim http://orcid.org/0000-0002-4146-6363
Tsankov, Alexander M.
Whitsett, Jeffrey http://orcid.org/0000-0003-1668-5174
Xu, Yan http://orcid.org/0000-0003-2025-027X
Banovich, Nicholas E.
Barbry, Pascal http://orcid.org/0000-0001-9632-6483
Duong, Thu Elizabeth http://orcid.org/0000-0001-7122-4448
Falk, Christine S.
Meyer, Kerstin B. http://orcid.org/0000-0001-5906-1498
Kropski, Jonathan A. http://orcid.org/0000-0002-8923-1344
Pe’er, Dana http://orcid.org/0000-0002-9259-8817
Schiller, Herbert B. http://orcid.org/0000-0001-9498-7034
Tata, Purushothama Rao http://orcid.org/0000-0003-4837-0337
Schultze, Joachim L.
Teichmann, Sara A. http://orcid.org/0000-0002-6294-6366
Misharin, Alexander V. http://orcid.org/0000-0003-2879-3789
Nawijn, Martijn C. http://orcid.org/0000-0003-3372-6521
Luecken, Malte D. http://orcid.org/0000-0001-7464-7921
Theis, Fabian J. http://orcid.org/0000-0002-2419-1943
,
Article History
Received: 10 March 2022
Accepted: 30 March 2023
First Online: 8 June 2023
Competing interests
: P.R.T. serves as a consultant for Surrozen, Cellarity and Celldom and is currently acting Chief Executive Officer of Iolux. F.J.T. consults for Immunai, Singularity Bio, CytoReason and Omniscope and has ownership interest in Dermagnostix and Cellarity. In the past 3 years, M.D.L. was a contractor for the CZI and received remuneration for talks at Pfizer and Janssen Pharmaceuticals. J.A.K. reports grants/contracts from Boehringer Ingelheim and Bristol Myers Squibb, consulting fees from Janssen and Boehringer Ingelheim and study support from Genentech and is a member of the scientific advisory board of APIE Therapeutics. In the past 3 years, S.A.T. has received remuneration for consulting and Scientific Advisory Board membership from Genentech, Roche, Biogen, GlaxoSmithKline, Foresite Labs and Qiagen. S.A.T. is a co-founder and board member of and holds equity in Transition Bio. D.S. is a founder of Pliant Therapeutics and a member of the Genentech Scientific Advisory Board and has a sponsored research agreement with AbbVie. N.K. served as a consultant to Boehringer Ingelheim, Third Rock, Pliant, Samumed, NuMedii, Theravance, LifeMax, Three Lakes Partners, Optikira, AstraZeneca, RohBar, Veracyte, Augmanity, CSL Behring, Galapagos and Thyron over the past 3 years and reports equity in Pliant and Thyron, grants from Veracyte, Boehringer Ingelheim and Bristol Myers Squibb and nonfinancial support from miRagen and AstraZeneca. N.K. owns intellectual property on novel biomarkers and therapeutics in IPF licensed to biotechnology. O.R.-R. is a co-inventor on patent applications (PCT/US2016/059233, PCT/US2018/064553, PCT/US2018/060860, PCT/US2017/016146, PCT/US2019/055894, PCT/US2018/064563, PCT/US2020/032933) filed by the Broad Institute for inventions related to single-cell genomics. O.R.-R. has been an employee of Genentech since 19 October 2020 and has equity in Roche. O.E. serves in an advisory capacity to Pieris Pharmaceuticals, Blade Therapeutics, Delta 4 and YAP Therapeutics. Y.B. holds a Canada Research Chair in the Genomics of Heart and Lung Diseases. The remaining authors declare no competing interests.